Emma Maclean is a Part-Time Lecturer and Module Coordinator in the Division of Occupational Therapy and Arts Therapies at Queen Margaret University. She holds qualifications including MA (Distinction), PG Dip, and BA (Joint Honours). Her roles include teaching on the MSc Music Therapy program, focusing on supervision for practice education placements and interdisciplinary studies. Education: MA (Distinction) in Music Therapy PG Dip in Music Therapy BA (Joint Honours) Research Interests: Partnership working, collaboration, evaluation, group work, and mental health across children, adults, and older populations. She employs research methods such as case studies and focus groups. Publications & Presentations: Her work includes a peer-reviewed article on partnership evaluation and a chapter in Arts Therapies in Schools . She co-presented a plenary session at the 2016 BAMT conference titled Music Therapy in a Changing Landscape . Affiliations: British Association for Music Therapy (BAMT) representative on Allied Health Professionals Federation Scotland (AHPFS) Registered with the Health and Care Professions Council Fellow of the Higher Education Academy Clinical Work: Works as a lead music therapist in the NHS, specializing in pediatric services, adult/older adult mental health (including dementia), and supervision. Engages in freelance violin performance with ceilidh bands, tango groups, and orchestras.
John P. O'Doherty serves as the Fletcher Jones Professor of Decision Neuroscience within Caltech's Division of Humanities and Social Sciences, holding continuous faculty appointments since 2004 (Assistant Professor 2004-07, Associate Professor 2007-09, Professor 2009-present, Fletcher Jones Professor 2021-present). He previously directed the Caltech Brain Imaging Center (2013-17) and maintains affiliations with the T&C Chen Center for Social and Decision Neuroscience. His educational background includes a B.A. from University of Dublin, Trinity College (1996) and D.Phil. from University of Oxford (2000). His research focuses on computational and neural mechanisms of reward-based learning and decision-making , employing fMRI, intracranial recordings, and mathematical modeling to investigate how the brain solves complex decision problems through evolutionarily conserved algorithms. Key areas include Reinforcement learning systems (model-based/model-free arbitration) Observational and social learning mechanisms Neural representation of value, risk, and uncertainty Computational phenotyping of mental disorders Temporal dynamics of goal persistence Analysis of his 2023-2025 publications reveals dominant trends in computational psychiatry (problem gambling, autism traits), hierarchical decision-making, and neuroeconomic modeling of social behavior. His work consistently integrates cross-species computational frameworks with human neuroimaging to identify transdiagnostic mechanisms. While specific awards beyond his endowed professorship aren't detailed, his leadership as Brain Imaging Center Director and prolific high-impact publications demonstrate significant recognition. Current advising includes graduate researcher Sneha Aenugu on goal-persistence projects, with administrative support from Mary A. Martin (mmartin@caltech.edu). His active research program continues to pioneer computational approaches to understanding decision pathologies.
Marc V Fuccillo is an Associate Professor of Neuroscience at the Perelman School of Medicine, University of Pennsylvania, where he leads a research laboratory focused on understanding the neural circuit mechanisms underlying behavioral control. His work bridges molecular, synaptic, and behavioral approaches to investigate how striatal circuits regulate mouse behavior from simple motor patterns to complex goal-directed actions. Fuccillo holds dual appointments in the Neuroscience and Cell and Molecular Biology Graduate Groups at Penn and maintains an active laboratory investigating the synaptic and circuit basis of neuropsychiatric disorders. Education: B.A. in Molecular and Cellular Biology and Music Performance (Violin) from Brown University (1998) Ph.D. in Developmental Genetics from New York University School of Medicine (2007) M.D. from New York University School of Medicine (2008) Fuccillo's research centers on the synaptic and circuit mechanisms of behavioral control, with particular emphasis on striatal circuits. His laboratory employs a range of technologies including mouse genetics, in vitro electrophysiology, in vivo imaging, and quantitative behavioral analysis to explore how neural circuits of the striatum regulate behavior and how disruptions in these circuits contribute to neuropsychiatric disorders. His work has particularly focused on autism-associated abnormalities in behavioral control, examining how synaptic adhesion molecules like neuroligins and neurexins shape circuit function and behavior, with significant findings regarding D1 dopamine receptor positive medium spiny neurons in the nucleus accumbens. Analysis of Fuccillo's recent publications reveals a strong focus on striatal circuit function across multiple dimensions. His work spans molecular neuroscience (examining synaptic adhesion molecules), cellular physiology (studying specific neuron types in striatal circuits), systems neuroscience (mapping circuit connectivity), and behavioral neuroscience (quantifying motor learning and decision-making). A unifying theme is how disruptions in specific molecular pathways lead to circuit-level abnormalities that manifest as behavioral phenotypes relevant to neuropsychiatric disorders, with particular attention to autism, OCD, and schizophrenia models. Scientific Recognition: Publications in high-impact journals including Nature Neuroscience, Current Biology, Cell Reports, and Neuron Research supported by multiple NIH grants including NIMH F32, NIMH K01, and HHMI Gilliam Fellowship awards for lab members Fuccillo actively mentors a diverse group of trainees including postdoctoral fellows, graduate students, and undergraduates. His laboratory has produced numerous successful alumni who have gone on to faculty positions, medical residencies, and graduate programs at prestigious institutions. His mentoring approach emphasizes technical skill development across multiple neuroscience disciplines while fostering independent scientific thinking. Current research in his lab is supported by NIH funding focused on understanding the molecular architecture of striatal circuits and their role in behavioral control, with three major research directions exploring molecular logic of striatal circuits, circuit mechanisms of behavioral control, and striatal dysfunction in neuropsychiatric disease models. The Fuccillo Laboratory operates within the Department of Neuroscience at the University of Pennsylvania, with access to state-of-the-art facilities for molecular, electrophysiological, imaging, and behavioral neuroscience research. The lab maintains active collaborations with other neuroscience research groups at Penn and beyond, creating a rich intellectual environment for studying the neural basis of behavior. Current research directions include investigating whether there is a molecular logic to striatal circuit composition, how striatal circuits shape behavioral control, and what mouse models of autism, schizophrenia, and OCD can reveal about striatal circuit dysfunction in disease pathophysiology.
Dr. Steven G. Clarke is a Distinguished Professor at UCLA Department of Chemistry & Biochemistry and director of research at the Molecular Biology Institute . His work bridges protein chemistry , methylation biology , and aging research through studies of spontaneous protein damage and its repair mechanisms. Education: BA in Chemistry and Zoology, Pomona College (magna cum laude, Phi Beta Kappa) PhD in Biochemistry and Molecular Biology, Harvard University (NSF Fellow) Postdoctoral Fellowship at UC Berkeley (Miller Fellow) Dr. Clarke's research focuses on protein isoaspartyl repair via PCMT1/PIMT enzymes , ribosomal protein methylation in Saccharomyces cerevisiae , and PRMT family characterization including PRMT7 and PRMT9. His lab combines biochemical assays , genetic models , and structural analysis to investigate aging mechanisms and disease implications. Recent publications highlight: COQ5 structure-function analysis in coenzyme Q biosynthesis PCMTD1 ubiquitin ligase interactions PRMT7 substrate specificity in histone H2B Protein isoaspartyl impacts on T cell function in lupus Novel PRMT inhibitors for cancer therapy Methionine addiction in osteosarcoma malignancy Major scientific awards: American Chemical Society Ralph F. Hirschmann Award in Peptide Chemistry NIH MERIT Award Ellison Medical Foundation Senior Scholar Award William C. Rose Award, ASBMB UCLA Distinguished Teaching Award (Eby Award winner) Current lab members include PhD candidates Eric Pang (UCSB) and Sining "Cindy" Wang (UCLA), while undergraduates Celeste Medina-Seymoure , Elizabeth Oroudjeva , Olivia Pacheco , and Jasmine Winter contribute to ongoing proteostasis studies. Collaborations with Profs. Jose Rodriguez and Catherine Clarke demonstrate interdisciplinary research approaches.
Soroush Saghafian is an Associate Professor of Public Policy at Harvard Kennedy School, specializing in applying operations research and machine learning to address public health challenges. He leads the Public Impact Analytics Science Lab (PIAS-Lab), focusing on analytics-driven solutions for societal problems. His research spans healthcare delivery optimization, emergency department efficiency, and public health policy. Notable collaborations include Massachusetts General Hospital and Harvard's Center for Health Decision Science. Awards include the INFORMS MSOM Responsible Research Award and the Pierskalla Award for healthcare research. Recent work includes studies on hospital closures' impacts, predictive analytics for bipolar disorder using Fitbit data, and policy implications of race in disease risk models. He teaches courses on machine learning and big data for public impact.
Dr. Xiaoxiao Li is an Assistant Professor in the Electrical and Computer Engineering Department at the University of British Columbia (UBC), with joint appointments in Computer Science (Associate Member) and the School of Medicine at Yale University (Adjunct Assistant Professor). She is also a Canada CIFAR AI Chair and Canada Research Chair (Tier II) in Responsible AI. Her research focuses on enhancing trustworthiness, fairness, and efficiency in AI algorithms and foundation models, particularly in healthcare applications. Education: B.S. (Honors) in Zhejiang University (2015), Ph.D. in Biomedical Engineering from Yale University (2020), Postdoc at Princeton University (2020-2021). She leads the Trusted and Efficient AI (TEA) Lab at UBC, which develops algorithms for federated learning, medical imaging analysis, and interpretable AI systems. Research interests include federated learning, generative models, medical image analysis, AI fairness, and graph-based methods for neuroimaging. Recent projects include GMValuator (data valuation for generative models), FairMedFM (fairness benchmarking in medical AI), and FedTextGrad (textual gradient-based FL optimization). Grants: Canada Foundation for Innovation Grant (2023), UBC Green Lab Fund (2023), Vector Institute funding Teaching: Courses on machine learning, federated learning, and AI ethics at UBC Awards & Recognition: Best Paper Award at FL@FM WWW 2024, Editorial Board Member of Medical Image Analysis , multiple top-tier conference acceptances (NeurIPS, ICLR, CVPR, MICCAI). Lab & Teams: TEA Lab collaborates with industry and hospitals to translate AI research into clinical tools. Current projects address AI fairness in healthcare, federated learning for medical data, and multimodal medical analytics.
Steve Chase is a Professor at Carnegie Mellon University , affiliated with the Biomedical Engineering , Electrical and Computer Engineering , Neuroscience Institute , and Robotics Institute departments. His research spans Computational Neuroscience , Neural Engineering , and Systems Neuroscience , with a focus on neural circuits, motor control, and brain-computer interfaces (BCI). Research Areas: Sensation & Perception, Methods Development, Diseases & Disorders, Physiological & Anatomical Methods. Lab Highlights: Development of the RotaWheel, memory trace studies in the motor cortex, and investigations into BCI stabilization and learning dynamics. Scientific Contributions: His lab has published extensively in journals like Neuron , Nature Computational Science , eLife , and PNAS , with notable works on neural activity patterns, dimensionality reduction in calcium imaging, and sensory constraints on motor cortex modulation. Students and postdocs in his lab have received awards, including the CNBC best paper award.
Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.
Takako Fujioka is an Associate Professor of Music at Stanford University, affiliated with the Center for Computer Research in Music and Acoustics (CCRMA). Her research focuses on the neural mechanisms underlying auditory perception, auditory-motor coupling, and music-supported therapy for neurorehabilitation. She holds a Ph.D. in Physiology from the Graduate University for Advanced Studies, Japan, and M.Sc./B.Eng. degrees in Electrical Engineering from Waseda University. Her work combines neurophysiological techniques such as MEG and EEG to study brain plasticity in development, aging, and stroke recovery. Notable contributions include investigating how music influences motor and cognitive recovery in stroke patients, as well as exploring the neural basis of musical perception through rhythmic synchronization and pitch discrimination studies. Supported by awards from the Canadian Institutes of Health Research during her postdoctoral work at the Rotman Research Institute, her research bridges clinical neuroscience and music cognition. Dr. Fujioka’s expertise spans auditory neuroscience, neurorehabilitation, and technology-assisted music therapy. She has pioneered studies on tactile mapping for cochlear implant users and networked music performance systems, emphasizing cross-modal perception and human-technology interaction. Her findings contribute to both theoretical understanding of auditory processing and practical applications in medical and educational settings. Awards: Canadian Institutes of Health Research Awards (postdoctoral phase) Labs/Teams: CCRMA, Stanford Music Perception Laboratory, Rotman Research Institute collaborations Key Themes: Neuroplasticity, Music-Mediated Rehabilitation, Auditory-Motor Integration, Multisensory Processing Her recent work examines aging-related changes in binaural hearing and the role of beta/gamma oscillations in rhythmic processing. She advocates for translational research that connects neural mechanisms with real-world therapeutic interventions.
Noorbakhsh Amiri Golilarz is an Assistant Professor in the Department of Computer Science at The University of Alabama, College of Engineering. He has established himself as a prominent researcher in artificial intelligence, particularly in computer vision, deep learning, and image processing. His educational background includes: Postdoctoral Research Fellow, Computer Science, Boston College (2023) Ph.D., Electrical and Computer Engineering, Southern Illinois University Carbondale (2023) D. Eng., Computer Science and Technology, University of Electronic Science and Technology of China (2021) M.S., Electrical and Electronic Engineering, Eastern Mediterranean University (2017) B.S., Electrical Engineering, University of Guilan (2012) Dr. Golilarz's research spans multiple domains of artificial intelligence with a particular focus on computer vision, deep learning, and image processing applications. His work addresses challenges in medical imaging, satellite imagery, and cognitive neuroscience. He has made significant contributions to image denoising techniques, control chart pattern recognition, and AI applications in healthcare. His recent work has expanded into generative AI, large language models, and secure machine learning operations. His publication portfolio demonstrates consistent productivity with over 2500 citations and an h-index of 25. His most impactful work includes applications of blockchain and federated learning for COVID-19 detection, optimized support vector machines for medical diagnosis, and innovative image denoising techniques using metaheuristic optimization algorithms. Among his professional achievements: Co-founded AI Letters journal in 2024, serving as Associate Editor-in-Chief Served as Lead Guest Editor and Topic Editor for several SCI-indexed journals Held the role of Conference Program Chair Dr. Golilarz has supervised numerous graduate students and research projects, with his work spanning theoretical advancements in AI algorithms to practical applications in healthcare, energy systems, and cybersecurity. His research group has established collaborations with institutions including Boston College and Mississippi State University.
John D. Murray is the Gregg L. Engles Associate Professor of Psychological and Brain Sciences at Dartmouth College and an Adjunct Associate Professor of Psychiatry at Yale School of Medicine. He holds a PhD in Physics from Yale University (2013) and a BS in Physics and Mathematics from Yale (2006). His research focuses on computational neuroscience and computational psychiatry, with secondary appointments in Physics and Neuroscience at Yale until 2023. His work integrates computational modeling, neuroimaging, and systems neuroscience to study decision-making processes, cortical organization, and psychiatric disorders. Collaborators include prominent researchers like Dr. John Krystal and Dr. Anticevic. Research interests include hierarchical brain organization, neuroimaging analysis techniques, and pharmacological effects on neural circuits. His lab (Murray Lab) develops computational tools like PsychRNN for cognitive task modeling. Notable contributions include linking transcriptomic data to neuroimaging patterns and modeling LSD’s effects on brain topography. He has been featured in YaleNews and Nature Communications for innovations in mapping mental illness variability and neural circuit dynamics. Grants and collaborations span translational neuroscience, addiction, and PTSD research through partnerships with Yale’s Center for Biomedical Data Science and VA National Center for PTSD. His interdisciplinary approach bridges physics, computer science, and clinical psychiatry to advance understanding of brain function and dysfunction.
Kora DeBeck is a Distinguished Professor of Substance Use and Drug Policy in the School of Public Policy at Simon Fraser University, a CIHR Applied Public Health Chair, and Dorothy Killam Fellow. She is also a Research Scientist with the BC Centre on Substance Use and Principal Investigator of the At-Risk Youth Study (ARYS), a longitudinal cohort tracking over 1,200 street-involved youth. Her research focuses on substance use policy, health services for marginalized populations, and the structural drivers of drug-related harms. She has published over 200 peer-reviewed articles challenging ineffective drug enforcement models and advocating for policy reforms. Recent publications analyze trends in opioid use, harm reduction during the COVID-19 pandemic, drug decriminalization, and youth-focused interventions. Her work consistently addresses social inequities through data-driven approaches to the toxic drug crisis. CIHR Applied Public Health Chair Dorothy Killam Fellow Michael Smith Health Research BC Scholar Award Distinguished SFU Professorship She has secured over $50 million in research funding, including $21M as principal investigator for ARYS. Her lab collaborates with healthcare providers, community organizations, and policymakers to translate research into practice.
Sushmita Roy is a Professor at the University of Wisconsin–Madison, affiliated with the Department of Computer Sciences and the College of Letters and Science. Her research focuses on developing computational methods in statistical machine learning to understand gene regulatory networks in living cells, particularly under environmental, developmental, disease, and evolutionary contexts. She explores bulk and single-cell genomic data integration to study processes like cell fate specification, host-microbe interactions, and diseases such as cancer and neurodevelopmental disorders. Her work emphasizes three key areas: inference of genome-scale transcriptional networks, evolutionary analysis of regulatory networks, and 3D genome organization dynamics. Roy’s lab collaborates across disciplines, leveraging genomic data from plant and mammalian systems. She has contributed to methodologies for analyzing chromatin accessibility, single-cell profiling, and network-based models of pathogen systems. Her affiliations include Wisconsin Institutes for Discovery, and she is a leader in computational biology and systems genomics research.
Professor Carlo Pappone is a Full Professor of Cardiology at Vita-Salute San Raffaele University (since 2019) and Director of the Arrhythmology Department at IRCCS Policlinico San Donato Hospital (since 2015). He has held previous academic/clinical leadership roles at IRCCS San Raffaele Hospital (2000-2010), Villa Maria Cecilia Hospital (2010-2015), and University of Naples Federico II (1990-2000). With 212 publications in top journals like NEJM, JAMA, and Circulation, he has made significant contributions to cardiac arrhythmia research. Current Positions Vita-Salute San Raffaele University (2019-present): Full Professor of Cardiology IRCCS Policlinico San Donato Hospital (2015-present): Director of Arrhythmology Department Previous Roles University of Naples Federico II (1990-2000) University of Michigan Ann Harbor (1990-2000) IRCCS San Raffaele Hospital (2000-2010) Villa Maria Cecilia Hospital (2010-2015) Research Focus: Specializing in cardiovascular diseases, his work spans atrial fibrillation ablation techniques, Brugada syndrome pathogenesis, heart failure device therapy, and ion channel disorders. His H-index of 53 and 18,407 citations reflect his substantial academic impact. Notable Scientific Contributions Author of 44 patents Principal Investigator in 14 clinical trials (clinicaltrials.gov) Developed circumferential pulmonary vein ablation technique Innovator in biventricular pacing systems for heart failure Pioneered research on non-excitatory current for cardiac contractility Scientific Recognition Awarded as Elite Reviewer of JACC (2005) Editorial Board Member of 6 leading journals Reviewer for NEJM, JAMA, Lancet, and Nature Medicine Education Medical Doctorate: University of Naples Federico II
Cara Lena Crook, PhD, is an Assistant Professor in the Department of Neurology at Yale School of Medicine. She specializes in neuropsychology, focusing on how brain function affects cognition, emotion, and behavior in patients with neurological and psychological conditions. Institution: Yale School of Medicine Department: Neurology Academic Rank: Assistant Professor Dr. Crook earned her PhD in Clinical Neuropsychology from Fordham University, completed her residency at Alpert Medical School of Brown University, and a fellowship at VA Boston Healthcare System, where she advanced her skills in neuropsychological assessment and intervention. Her research and clinical interests center on understanding the neural basis of cognitive and emotional processes. She works at the intersection of neurology and psychology, contributing to patient care, teaching, and scholarly activity in clinical neuropsychology. Though specific publications are not listed, her work likely spans assessment methodologies, cognitive disorders, and brain-behavior relationships in neurological populations. Dr. Crook is actively engaged in the academic and clinical missions at Yale, with no indication of part-time status or retirement. She is not noted as a former staff member and is currently contributing to the department’s educational and research initiatives. PhD: Fordham University, Clinical Neuropsychology (2022) Residency: Alpert Medical School of Brown University, Neuropsychology (2022) Fellowship: VA Boston Healthcare System (2024) She has not been cited as having formal advisees or receiving specific scientific awards in the available text. There is no mention of grants, labs, or research teams she leads, though her fellowship and academic appointments suggest active involvement in clinical research and training.
